- Pain Summit 2018
|Evidence-Basis of Cannabinoid Medicine for Pain Management | Pain Management Conference|
An Update On the Evidence-Basis of Cannabinoid Medicine for Pain Management
Faculty: Michael E. Schatman, PhD, CPE
Cannabinoid medicine has become a hot button issue in the United States especially regarding legal regulations, safety profiles, and clinical efficacy. Learn about the political issues surrounding the legalization of medical marijuana in the United States; the legal realities and empirical data; the pros and cons of appropriate and efficacious use of cannabinoids for the treatment of chronic pain; and more.
Michael E. Schatman, PhD, CPE, is a clinical psychologist who has spent the past 32 years working in multidisciplinary chronic pain management. He is currently on the teaching faculty of the Department of Public Health & Community Medicine at the Tufts University School of Medicine, and serves as Director of Research and Network Development for Boston Pain Care in Waltham, MA. Dr. Schatman is the author of over 100 journal articles and book chapters on various aspects of chronic pain management, and lectures regularly on pain management on local, national and international bases. He is also the editor of Ethical Issues in Chronic Pain Management and Chronic Pain Management: Guidelines for Multidisciplinary Program Development, both of which were released by Informa Healthcare in 2007. Dr. Schatman is a member of the Editorial Boards of numerous journals. For the past 5 years, he has served as the Editor-in-Chief of the Journal of Pain Research. He is the past-Chairperson of the Ethics Special Interest Group of the American Pain Society, is a member of the Ethics Committee of the American Pain Society, the Ethics Council of the American Academy of Pain Medicine, and is on the Board of Directors of the American Society of Pain Educators – which named him 2011 Clinical Pain Educator of the Year.
Dr. Schatman reports that he is a consultant for kaléo.